AFT guides to upper end of forecast as virus boosts sales

By Jenny Ruth | Tue, 10 Mar 2020


AFT Pharmaceuticals is reporting brisk demand for its cold and influenza-related medicines amid the unfolding coronavirus crisis, although that may not be enough to fully offset the supply-chain disruptions it is grappling with."As news of the covid-19 outbreak emerged at the start of this year, we moved quickly to significantly build stocks of our key medicines in Australasia and we have been rewarded for this foresight," managing director Hartley Atkinson said in a statement."By way of example, we sold $1.2 million of vitamin C lipo-sachets i...